Structural Heart Market Analysis 2025–2029: Growth Forecast and Competitive Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the structural heart market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Structural Heart Market Be Worth By 2029, And What CAGR Will It Achieve?

The structural heart market has experienced substantial growth in recent years. It is anticipated to expand from $14.9 billion in 2024 to $15.89 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. The expansion observed in the past can be attributed to enhanced awareness and screening procedures, strengthened supply chain resilience, increasing healthcare expenditure, market consolidation, and a heightened understanding of cardiovascular diseases.

The structural heart market is projected to experience robust expansion over the coming years, with its size anticipated to reach $22.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. This growth during the forecast period is primarily attributed to the increasing demand for heart valve devices, an expanding aging population, the growing burden of cardiovascular diseases, strategic market segmentation, and regional market advancements. Key trends expected over this period include the introduction of new products, continuous technological progress, economic recovery, regulatory measures, the rising incidence of cardiovascular diseases, and the emergence of innovative medical devices.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

Which Factors Are Driving The Structural Heart Market Forward?

The increasing occurrence of cardiovascular conditions is projected to boost the expansion of the structural heart market. These disorders are illnesses impacting the heart and blood vessels, encompassing ailments like coronary artery disease, heart failure, and stroke. The growing incidence of cardiovascular disorders primarily stems from an aging population, shifts in lifestyle and diet, and rising levels of obesity and diabetes. Structural heart devices and services facilitate the diagnosis and treatment of abnormalities or conditions affecting the valves, chambers, and adjacent tissues of the heart. These procedures are minimally invasive, offering an efficient treatment alternative to open-heart surgery with reduced complication risks. For example, a report from August 2022 by the American College of Cardiology, a US-based non-profit medical association, projects a rise in all four key cardiovascular risk factors in the United States between 2025 and 2060. Diabetes is foreseen to have the most significant percentage increase at 39.3%, reaching 55 million people, followed by dyslipidemia at 27.6% (126 million), hypertension at 25.1% (162 million), and obesity at 18.3% (126 million). Furthermore, researchers noted that the most considerable anticipated increases in specific cardiovascular disease rates are for stroke, with a 33.8% rise to 15 million, and heart failure, increasing by 33.4% to 13 million. Ischemic heart disease is also expected to rise by 30.7% to 29 million, and heart attack by 16.9% to 16 million. Consequently, the increasing occurrence of cardiovascular ailments is fueling the expansion of the structural heart market.

Which Segments Form The Key Structure Of The Structural Heart Market?

The structural heartmarket covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

What Strategic Shifts And Innovations Are Influencing The Structural Heart Market?

Technological progress has surfaced as a prominent trend, becoming increasingly prevalent within the structural heart market. Leading companies active in the structural heart sector are focusing their endeavors on developing groundbreaking products to solidify their standing in the market. As an example, during February 2023, Eko Health, a US-based digital health firm, introduced the SENSORA platform, designed for non-invasive cardiac disease detection in primary care settings. SENSORA incorporates artificial intelligence capable of objectively pinpointing structural murmurs, which indicate valvular heart disease, alongside care pathway analytics software. This software offers downstream insight and metrics regarding the patient’s progression through the healthcare system by capturing and analyzing heart sounds and electrical signals using its digital stethoscopes. Its purpose is to assist crucial decision-making by identifying gaps in care, which can lead to improved operational efficiency, including shorter delays in care provision, reduced hospital stays, and lower readmission rates, simultaneously boosting both patient and physician satisfaction.

Which Firms Are Making The Biggest Impact In The Structural Heart Market?

Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q’Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Is Expected To Lead The Structural Heart Market In The Next Few Years?

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Browse Through More Reports Similar to the Global Structural Heart Market 2025, By The Business Research Company

Dermatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795